As we have demonstrated that intramembrane cleavage of AXL-FL actively occurs in cancer cells (Figs. 1 and 3), we wondered whether the γ-secretase–mediated processing of AXL plays a role in the drug resistance of TKIs. Here, AXL is linked to cancer.